| CoR | Nuclear Receptor Co-Repressor | 
| COVID-19 | CoronaVirus Disease 2019 | 
| DAD | Deacetylase-Activating Domain | 
| EMT | Epithelial-to-Mesenchymal Transition | 
| FDA | Food and Drug Administration | 
| FK228 | Romidepsin | 
| FPKM | Fragments Per Kilobase of transcript length per Million of mapped reads | 
| GTEx | Genotype-Tissue Expression project | 
| HAT | Histone Acetyltransferase | 
| HCC | Hepatocellular Carcinoma | 
| HDAC | Histone Deacetylase | 
| HDACi | Histone Deacetylase inhibitor | 
| IFN | Interferon | 
| LBH589 | Panobinostat | 
| LSD1 | Lysine Demethylase 1 | 
| MEF2 | Myocyte Enhancer Factor 2 | 
| NES | Nuclear Exporting Signal | 
| MGCD0103 | Mocetinostat | 
| MiDac | Mitotic Deacetylase Complex | 
| MS-275 | Entinostat | 
| NBL | Neuroblastoma | 
| NLS | Nuclear Localization Sequence | 
| NR | Nuclear Receptor | 
| NuRD | Nucleosome Remodeling Deacetylase | 
| PTM | Post-Translational Modification | 
| PXD101 | Belinostat | 
| RD | Repression Domain | 
| REST | RE1 Silencing Transcription Factor | 
| SAHA | Vorinostat | 
| SARS-CoV-2 | Severe Acute Respiratory Syndrome CoronaVirus 2 | 
| SIRT | Sirtuins | 
| SMN | Survival of MotoNeurons | 
| TCGA | The Cancer Genome Atlas | 
| TF | Transcription Factor | 
| TNBS | Triple Negative Breast Cancer | 
| TSA | Thrichostatin A | 
| TSS | Transcription Start Site | 
| VPA | Valproic Acid |